Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Postmenopausal Breast Cancer”

530 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 530 results

Testing effectiveness (Phase 2)UnknownNCT02646735
What this trial is testing

Fulvestrant 500mg With Exemestane Endocrine Therapy for Postmenopausal Advanced Breast Cancer Patients

Who this might be right for
Breast Cancer
Chinese Academy of Medical Sciences 148
Large-scale testing (Phase 3)Study completedNCT00190593
What this trial is testing

Raloxifene Use for The Heart

Who this might be right for
Cardiovascular DiseasesBreast Neoplasms
Eli Lilly and Company 10,000
Not applicableStudy completedNCT01384838
What this trial is testing

Exercise Training in Postmenopausal Patients With Breast Cancer

Who this might be right for
Physical Activity
Arbeitsgemeinschaft medikamentoese Tumortherapie 80
Very early researchStudy completedNCT02538484
What this trial is testing

Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects

Who this might be right for
Breast Cancer
The University of Texas Health Science Center at San Antonio 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04544189
What this trial is testing

Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer

Who this might be right for
Breast Neoplasms
Novartis Pharmaceuticals 69
Not applicableStudy completedNCT00591747
What this trial is testing

Strength Training for Older Breast Cancer Survivors

Who this might be right for
Breast NeoplasmOsteoporosis, Postmenopausal
OHSU Knight Cancer Institute 106
Large-scale testing (Phase 3)Study completedNCT00784940
What this trial is testing

ATAC - Bone Density Sub-Protocol

Who this might be right for
Bone Density
AstraZeneca 308
Large-scale testing (Phase 3)Study completedNCT00072462
What this trial is testing

Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ

Who this might be right for
Breast Cancer
Queen Mary University of London 2,980
Post-approval studies (Phase 4)Not Yet RecruitingNCT04137640
What this trial is testing

Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
Shengjing Hospital 152
Not applicableWithdrawnNCT00329017
What this trial is testing

Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
Carol Fabian, MD
Testing effectiveness (Phase 2)Study completedNCT00247650
What this trial is testing

Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy

Who this might be right for
Breast Cancer
Novartis 190
Early research (Phase 1)Study completedNCT05438303
What this trial is testing

Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers

Who this might be right for
Healthy Volunteers
AstraZeneca 59
Not applicableStudy completedNCT00830973
What this trial is testing

The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer

Who this might be right for
Breast NeoplasmsTamoxifen
Medco Health Solutions, Inc. 184
Testing effectiveness (Phase 2)Study completedNCT00038103
What this trial is testing

Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen

Who this might be right for
Breast Neoplasms
Pfizer 111
Testing effectiveness (Phase 2)Study completedNCT02598557
What this trial is testing

Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer

Who this might be right for
Stage 0 Breast Cancer AJCC v6 and v7Stage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+4 more
National Cancer Institute (NCI) 180
Testing effectiveness (Phase 2)UnknownNCT03913234
What this trial is testing

Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients

Who this might be right for
HER2-positive Breast CancerPostmenopausalMetastatic Breast Cancer
Yonsei University 95
Not applicableStudy completedNCT00885612
What this trial is testing

10 Year Coronary Heart Disease (CHD) Risk Evaluation and Its Treatment Pattern Analysis in Postmenopausal Early Breast Cancer (EBC) Patients Taking Aromatase Inhibitors (AI)

Who this might be right for
Breast Cancer
AstraZeneca 1,114
Testing effectiveness (Phase 2)Study completedNCT00107016
What this trial is testing

Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women

Who this might be right for
Breast Neoplasm
Novartis Pharmaceuticals 267
Early research (Phase 1)Study completedNCT00328120
What this trial is testing

Faslodex 500mg Multiple Dose Tolerability Study in BC Patients

Who this might be right for
Advanced Breast Cancer
AstraZeneca 20
Testing effectiveness (Phase 2)Study completedNCT00629616
What this trial is testing

Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer

Who this might be right for
Breast Cancer
UNICANCER 116
Load More Results